← Back to Search

Behavior Management for Psychosocial Intervention(MCB-ADHD Trial)

Dartmouth-Hitchcock Medical Center, Lebanon, NH
Managing Challenging Behaviors in ADHD; Psychosocial programN/ARecruitingResearch Sponsored by Dartmouth-Hitchcock Medical Center

MCB-ADHD Trial Summary

This trial tests whether a short, time-limited parent education program can help families of children diagnosed with ADHD and disruptive behaviors. Parents/caregivers will fill out questionnaires to measure changes in behavior, parenting practices and perceptions of mental health care.

MCB-ADHD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline, 14 weeks post baseline, and 24 weeks post baseline.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline, 14 weeks post baseline, and 24 weeks post baseline. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in ADHD-5
Change in Eyberg Child Behavior Inventory
Change in Impairment Rating Scale
+3 more
Secondary outcome measures
Changes in Family Empowerment Scale
Changes in the Barriers to Children's Mental Health Survey
Changes in the Parenting Scale (PS; Rhodes & Leary, 2007).

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

MCB-ADHD Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Managing Challenging Behaviors in ADHDExperimental Treatment1 Intervention
This is a 7-session behavioral parent training delivered to children ages 3-7 referred to the study after an initial ADHD diagnosis or when challenging behaviors are identified by their medical provider.
Group II: Wait ListActive Control1 Intervention
Families assigned to the wait list will complete measures at baseline, 14 weeks, and 24 weeks. After 24 weeks they will be offered the experimental treatment.

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor
516 Previous Clinical Trials
2,543,523 Total Patients Enrolled

Media Library

Psychosocial Intervention Research Study Groups: Managing Challenging Behaviors in ADHD, Wait List
Psychosocial Intervention Clinical Trial 2023: Managing Challenging Behaviors in ADHD Highlights & Side Effects. Trial Name: NCT05674968 — N/A
Managing Challenging Behaviors in ADHD 2023 Treatment Timeline for Medical Study. Trial Name: NCT05674968 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the research project encompass individuals below 30 years of age?

"Per the study's admission parameters, only individuals aged 3 to 8 may enroll in this trial."

Answered by AI

Does this exploratory research still have room for participants?

"According to clinicaltrials.gov, this medical research is recruiting volunteers for participation. Last edited on the 29th of December 2022 and initially posted on October 10th, it continues seeking patient input."

Answered by AI

To what extent is participation in this investigation limited?

"Affirmative. According to information available on clinicaltrials.gov, this medical experiment initiated recruiting on October 10th 2022 and is still searching for study participants. Specifically, 60 individuals are needed from 1 trial site."

Answered by AI

Who else is applying?

What state do they live in?
What site did they apply to?
Dartmouth-Hitchcock Medical Center
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
~29 spots leftby Nov 2024